Global PARP Inhibitor Biomarkers Market Size, Share & Trends Analysis Report By Product (Kits, and Assays), By Application, By Services (BRCA 1 & 2 Testing, HRD Testing, HRR Testing, and Others), By Regional Outlook and Forecast, 2024 - 2031

The Global PARP Inhibitor Biomarkers Market size is expected to reach $1.6 billion by 2031, rising at a market growth of 8.3% CAGR during the forecast period.

North America boasts advanced healthcare infrastructure, including well-established clinical laboratories, oncology centres, and research institutions. Thus, the North America region acquired 42.5% revenue share in the market 2023. The availability of diagnostic technologies and skilled healthcare professionals enhances the accessibility and utilization of biomarker testing services, driving the demand for it in North America.

Oncology research is continually uncovering new biomarkers associated with cancer development, progression, and response to therapy. As our understanding of the molecular pathways underlying cancer improves, researchers are identifying biomarkers that predict response to specific treatments, including it.

Additionally, point-of-care testing brings diagnostic capabilities closer to the patient, enabling biomarker testing to be performed outside traditional laboratory settings, such as outpatient clinics, physician offices, or even the patient’s home. Hence, the expansion of point-of-care testing is raising the market’s growth.

However, Biomarker testing often involves sophisticated laboratory techniques and specialized equipment, which can be expensive to procure and maintain. Additionally, the cost of reagents, consumables, and personnel required for biomarker testing adds to the overall expense. In conclusion, the high cost of biomarker testing hinders the market’s growth.

Economic hardships and changes in healthcare priorities during the pandemic affected patient access to cancer treatments, including this. Financial constraints, job losses, and changes in insurance coverage may have influenced treatment decisions and patient adherence. Thus, the COVID-19 pandemic had a negative impact on the market.

Product Outlook

Based on product, the market is divided into kits and assays. In 2023, the kits segment garnered 63.8% revenue share in the market. Biomarker testing kits offer a user-friendly and convenient solution for healthcare providers to perform biomarker testing in-house without requiring specialized laboratory infrastructure or expertise.

Application Outlook

Based on application, the market is categorized into breast cancer, ovarian cancer, and others. The ovarian cancer segment witnessed 30.7% revenue share in the market in 2023. PARP inhibitors have demonstrated clinical efficacy in treating ovarian cancer patients with BRCA mutations. Clinical trials have shown that PARP inhibitors.

Services Outlook

On the basis of services, the market is segmented into BRCA 1 & 2 testing, HRD testing, HRR testing, and others. The BRCA 1 & 2 testing segment recorded 41.8% revenue share in the market in 2023. BRCA1 and BRCA2 mutations are strongly associated with increased sensitivity to this in certain cancers, particularly breast and ovarian cancer.

Free Valuable Insights: Global PARP Inhibitor Biomarkers Market size to reach USD 1.6 Billion by 2031

Regional Outlook

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Asia Pacific region generated 24.4% revenue share in the market. The Asia Pacific region is experiencing a significant increase in the incidence of cancer, including breast, ovarian, and other cancers associated with PARP inhibitor therapy.

PARP Inhibitor Biomarkers Market Report Coverage

Report Attribute	Details
Market size value in 2023	USD 871.3 Million
Market size forecast in 2031	USD 1.6 Billion
Base Year	2023
Historical Period	2020 to 2022
Forecast Period	2024 to 2031
Revenue Growth Rate	CAGR of 8.3% from 2024 to 2031
Number of Pages	223
Number of Tables	250
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives
Segments covered	Product, Services, Application, Region
Country scope	North America (US, Canada, Mexico, and Rest of North America) Europe (Germany, UK, France, Russia, Spain, Italy, and Rest of Europe) Asia Pacific (China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific) LAMEA (Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA)
Companies Included	Myriad Genetics, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., NeoGenomics Laboratories, Qiagen N.V, Agilent Technologies, Inc., Merck KGaA, Bayer AG, AstraZeneca PLC, GlaxoSmithKline PLC (GSK)

List of Key Companies Profiled

• Myriad Genetics, Inc.
• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• NeoGenomics Laboratories
• Qiagen N.V
• Agilent Technologies, Inc.
• Merck KGaA
• Bayer AG
• AstraZeneca PLC
• GlaxoSmithKline PLC (GSK)

PARP Inhibitor Biomarkers Market Report Segmentation

By Product

• Kits
• Assays

By Application

• Breast Cancer
• Ovarian Cancer
• Others

By Services

• BRCA 1 & 2 Testing
• HRD Testing
• HRR Testing
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global PARP Inhibitor Biomarkers Market, by Product
1.4.2 Global PARP Inhibitor Biomarkers Market, by Application
1.4.3 Global PARP Inhibitor Biomarkers Market, by Services
1.4.4 Global PARP Inhibitor Biomarkers Market, by Geography
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. Global PARP Inhibitor Biomarkers Market by Product
4.1 Global Kits Market by Region
4.2 Global Assays Market by Region

Chapter 5. Global PARP Inhibitor Biomarkers Market by Application
5.1 Global Breast Cancer Market by Region
5.2 Global Ovarian Cancer Market by Region
5.3 Global Others Market by Region

Chapter 6. Global PARP Inhibitor Biomarkers Market by Services
6.1 Global BRCA 1 & 2 Testing Market by Region
6.2 Global HRD Testing Market by Region
6.3 Global HRR Testing Market by Region
6.4 Global Others Market by Region

Chapter 7. Global PARP Inhibitor Biomarkers Market by Region
7.1 North America PARP Inhibitor Biomarkers Market
7.1.1 North America PARP Inhibitor Biomarkers Market by Product
7.1.1.1 North America Kits Market by Region
7.1.1.2 North America Assays Market by Region
7.1.2 North America PARP Inhibitor Biomarkers Market by Application
7.1.2.1 North America Breast Cancer Market by Country
7.1.2.2 North America Ovarian Cancer Market by Country
7.1.2.3 North America Others Market by Country
7.1.3 North America PARP Inhibitor Biomarkers Market by Services
7.1.3.1 North America BRCA 1 & 2 Testing Market by Country
7.1.3.2 North America HRD Testing Market by Country
7.1.3.3 North America HRR Testing Market by Country
7.1.3.4 North America Others Market by Country
7.1.4 North America PARP Inhibitor Biomarkers Market by Country
7.1.4.1 US PARP Inhibitor Biomarkers Market
7.1.4.1.1 US PARP Inhibitor Biomarkers Market by Product
7.1.4.1.2 US PARP Inhibitor Biomarkers Market by Application
7.1.4.1.3 US PARP Inhibitor Biomarkers Market by Services
7.1.4.2 Canada PARP Inhibitor Biomarkers Market
7.1.4.2.1 Canada PARP Inhibitor Biomarkers Market by Product
7.1.4.2.2 Canada PARP Inhibitor Biomarkers Market by Application
7.1.4.2.3 Canada PARP Inhibitor Biomarkers Market by Services
7.1.4.3 Mexico PARP Inhibitor Biomarkers Market
7.1.4.3.1 Mexico PARP Inhibitor Biomarkers Market by Product
7.1.4.3.2 Mexico PARP Inhibitor Biomarkers Market by Application
7.1.4.3.3 Mexico PARP Inhibitor Biomarkers Market by Services
7.1.4.4 Rest of North America PARP Inhibitor Biomarkers Market
7.1.4.4.1 Rest of North America PARP Inhibitor Biomarkers Market by Product
7.1.4.4.2 Rest of North America PARP Inhibitor Biomarkers Market by Application
7.1.4.4.3 Rest of North America PARP Inhibitor Biomarkers Market by Services
7.2 Europe PARP Inhibitor Biomarkers Market
7.2.1 Europe PARP Inhibitor Biomarkers Market by Product
7.2.1.1 Europe Kits Market by Country
7.2.1.2 Europe Assays Market by Country
7.2.2 Europe PARP Inhibitor Biomarkers Market by Application
7.2.2.1 Europe Breast Cancer Market by Country
7.2.2.2 Europe Ovarian Cancer Market by Country
7.2.2.3 Europe Others Market by Country
7.2.3 Europe PARP Inhibitor Biomarkers Market by Services
7.2.3.1 Europe BRCA 1 & 2 Testing Market by Country
7.2.3.2 Europe HRD Testing Market by Country
7.2.3.3 Europe HRR Testing Market by Country
7.2.3.4 Europe Others Market by Country
7.2.4 Europe PARP Inhibitor Biomarkers Market by Country
7.2.4.1 Germany PARP Inhibitor Biomarkers Market
7.2.4.1.1 Germany PARP Inhibitor Biomarkers Market by Product
7.2.4.1.2 Germany PARP Inhibitor Biomarkers Market by Application
7.2.4.1.3 Germany PARP Inhibitor Biomarkers Market by Services
7.2.4.2 UK PARP Inhibitor Biomarkers Market
7.2.4.2.1 UK PARP Inhibitor Biomarkers Market by Product
7.2.4.2.2 UK PARP Inhibitor Biomarkers Market by Application
7.2.4.2.3 UK PARP Inhibitor Biomarkers Market by Services
7.2.4.3 France PARP Inhibitor Biomarkers Market
7.2.4.3.1 France PARP Inhibitor Biomarkers Market by Product
7.2.4.3.2 France PARP Inhibitor Biomarkers Market by Application
7.2.4.3.3 France PARP Inhibitor Biomarkers Market by Services
7.2.4.4 Russia PARP Inhibitor Biomarkers Market
7.2.4.4.1 Russia PARP Inhibitor Biomarkers Market by Product
7.2.4.4.2 Russia PARP Inhibitor Biomarkers Market by Application
7.2.4.4.3 Russia PARP Inhibitor Biomarkers Market by Services
7.2.4.5 Spain PARP Inhibitor Biomarkers Market
7.2.4.5.1 Spain PARP Inhibitor Biomarkers Market by Product
7.2.4.5.2 Spain PARP Inhibitor Biomarkers Market by Application
7.2.4.5.3 Spain PARP Inhibitor Biomarkers Market by Services
7.2.4.6 Italy PARP Inhibitor Biomarkers Market
7.2.4.6.1 Italy PARP Inhibitor Biomarkers Market by Product
7.2.4.6.2 Italy PARP Inhibitor Biomarkers Market by Application
7.2.4.6.3 Italy PARP Inhibitor Biomarkers Market by Services
7.2.4.7 Rest of Europe PARP Inhibitor Biomarkers Market
7.2.4.7.1 Rest of Europe PARP Inhibitor Biomarkers Market by Product
7.2.4.7.2 Rest of Europe PARP Inhibitor Biomarkers Market by Application
7.2.4.7.3 Rest of Europe PARP Inhibitor Biomarkers Market by Services
7.3 Asia Pacific PARP Inhibitor Biomarkers Market
7.3.1 Asia Pacific PARP Inhibitor Biomarkers Market by Product
7.3.1.1 Asia Pacific Kits Market by Country
7.3.1.2 Asia Pacific Assays Market by Country
7.3.2 Asia Pacific PARP Inhibitor Biomarkers Market by Application
7.3.2.1 Asia Pacific Breast Cancer Market by Country
7.3.2.2 Asia Pacific Ovarian Cancer Market by Country
7.3.2.3 Asia Pacific Others Market by Country
7.3.3 Asia Pacific PARP Inhibitor Biomarkers Market by Services
7.3.3.1 Asia Pacific BRCA 1 & 2 Testing Market by Country
7.3.3.2 Asia Pacific HRD Testing Market by Country
7.3.3.3 Asia Pacific HRR Testing Market by Country
7.3.3.4 Asia Pacific Others Market by Country
7.3.4 Asia Pacific PARP Inhibitor Biomarkers Market by Country
7.3.4.1 China PARP Inhibitor Biomarkers Market
7.3.4.1.1 China PARP Inhibitor Biomarkers Market by Product
7.3.4.1.2 China PARP Inhibitor Biomarkers Market by Application
7.3.4.1.3 China PARP Inhibitor Biomarkers Market by Services
7.3.4.2 Japan PARP Inhibitor Biomarkers Market
7.3.4.2.1 Japan PARP Inhibitor Biomarkers Market by Product
7.3.4.2.2 Japan PARP Inhibitor Biomarkers Market by Application
7.3.4.2.3 Japan PARP Inhibitor Biomarkers Market by Services
7.3.4.3 India PARP Inhibitor Biomarkers Market
7.3.4.3.1 India PARP Inhibitor Biomarkers Market by Product
7.3.4.3.2 India PARP Inhibitor Biomarkers Market by Application
7.3.4.3.3 India PARP Inhibitor Biomarkers Market by Services
7.3.4.4 South Korea PARP Inhibitor Biomarkers Market
7.3.4.4.1 South Korea PARP Inhibitor Biomarkers Market by Product
7.3.4.4.2 South Korea PARP Inhibitor Biomarkers Market by Application
7.3.4.4.3 South Korea PARP Inhibitor Biomarkers Market by Services
7.3.4.5 Singapore PARP Inhibitor Biomarkers Market
7.3.4.5.1 Singapore PARP Inhibitor Biomarkers Market by Product
7.3.4.5.2 Singapore PARP Inhibitor Biomarkers Market by Application
7.3.4.5.3 Singapore PARP Inhibitor Biomarkers Market by Services
7.3.4.6 Malaysia PARP Inhibitor Biomarkers Market
7.3.4.6.1 Malaysia PARP Inhibitor Biomarkers Market by Product
7.3.4.6.2 Malaysia PARP Inhibitor Biomarkers Market by Application
7.3.4.6.3 Malaysia PARP Inhibitor Biomarkers Market by Services
7.3.4.7 Rest of Asia Pacific PARP Inhibitor Biomarkers Market
7.3.4.7.1 Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Product
7.3.4.7.2 Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Application
7.3.4.7.3 Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Services
7.4 LAMEA PARP Inhibitor Biomarkers Market
7.4.1 LAMEA PARP Inhibitor Biomarkers Market by Product
7.4.1.1 LAMEA Kits Market by Country
7.4.1.2 LAMEA Assays Market by Country
7.4.2 LAMEA PARP Inhibitor Biomarkers Market by Application
7.4.2.1 LAMEA Breast Cancer Market by Country
7.4.2.2 LAMEA Ovarian Cancer Market by Country
7.4.2.3 LAMEA Others Market by Country
7.4.3 LAMEA PARP Inhibitor Biomarkers Market by Services
7.4.3.1 LAMEA BRCA 1 & 2 Testing Market by Country
7.4.3.2 LAMEA HRD Testing Market by Country
7.4.3.3 LAMEA HRR Testing Market by Country
7.4.3.4 LAMEA Others Market by Country
7.4.4 LAMEA PARP Inhibitor Biomarkers Market by Country
7.4.4.1 Brazil PARP Inhibitor Biomarkers Market
7.4.4.1.1 Brazil PARP Inhibitor Biomarkers Market by Product
7.4.4.1.2 Brazil PARP Inhibitor Biomarkers Market by Application
7.4.4.1.3 Brazil PARP Inhibitor Biomarkers Market by Services
7.4.4.2 Argentina PARP Inhibitor Biomarkers Market
7.4.4.2.1 Argentina PARP Inhibitor Biomarkers Market by Product
7.4.4.2.2 Argentina PARP Inhibitor Biomarkers Market by Application
7.4.4.2.3 Argentina PARP Inhibitor Biomarkers Market by Services
7.4.4.3 UAE PARP Inhibitor Biomarkers Market
7.4.4.3.1 UAE PARP Inhibitor Biomarkers Market by Product
7.4.4.3.2 UAE PARP Inhibitor Biomarkers Market by Application
7.4.4.3.3 UAE PARP Inhibitor Biomarkers Market by Services
7.4.4.4 Saudi Arabia PARP Inhibitor Biomarkers Market
7.4.4.4.1 Saudi Arabia PARP Inhibitor Biomarkers Market by Product
7.4.4.4.2 Saudi Arabia PARP Inhibitor Biomarkers Market by Application
7.4.4.4.3 Saudi Arabia PARP Inhibitor Biomarkers Market by Services
7.4.4.5 South Africa PARP Inhibitor Biomarkers Market
7.4.4.5.1 South Africa PARP Inhibitor Biomarkers Market by Product
7.4.4.5.2 South Africa PARP Inhibitor Biomarkers Market by Application
7.4.4.5.3 South Africa PARP Inhibitor Biomarkers Market by Services
7.4.4.6 Nigeria PARP Inhibitor Biomarkers Market
7.4.4.6.1 Nigeria PARP Inhibitor Biomarkers Market by Product
7.4.4.6.2 Nigeria PARP Inhibitor Biomarkers Market by Application
7.4.4.6.3 Nigeria PARP Inhibitor Biomarkers Market by Services
7.4.4.7 Rest of LAMEA PARP Inhibitor Biomarkers Market
7.4.4.7.1 Rest of LAMEA PARP Inhibitor Biomarkers Market by Product
7.4.4.7.2 Rest of LAMEA PARP Inhibitor Biomarkers Market by Application
7.4.4.7.3 Rest of LAMEA PARP Inhibitor Biomarkers Market by Services

Chapter 8. Company Profiles
8.1 Myriad Genetics, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Research & Development Expenses
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 SWOT Analysis
8.3 Illumina, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segment and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 Neogenomics, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.5 Qiagen N.V.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Agilent Technologies, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 SWOT Analysis
8.7 Merck KGaA
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Bayer AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 AstraZeneca PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 SWOT Analysis
8.10. GlaxoSmithKline PLC (GSK)
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis

Chapter 9. Winning Imperatives of PARP Inhibitor Biomarkers Market

TABLE 1 Global PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 2 Global PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 3 Global PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 4 Global PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 5 Global Kits Market by Region, 2020 - 2023, USD Million
TABLE 6 Global Kits Market by Region, 2024 - 2031, USD Million
TABLE 7 Global Assays Market by Region, 2020 - 2023, USD Million
TABLE 8 Global Assays Market by Region, 2024 - 2031, USD Million
TABLE 9 Global PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 10 Global PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 11 Global Breast Cancer Market by Region, 2020 - 2023, USD Million
TABLE 12 Global Breast Cancer Market by Region, 2024 - 2031, USD Million
TABLE 13 Global Ovarian Cancer Market by Region, 2020 - 2023, USD Million
TABLE 14 Global Ovarian Cancer Market by Region, 2024 - 2031, USD Million
TABLE 15 Global Others Market by Region, 2020 - 2023, USD Million
TABLE 16 Global Others Market by Region, 2024 - 2031, USD Million
TABLE 17 Global PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 18 Global PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 19 Global BRCA 1 & 2 Testing Market by Region, 2020 - 2023, USD Million
TABLE 20 Global BRCA 1 & 2 Testing Market by Region, 2024 - 2031, USD Million
TABLE 21 Global HRD Testing Market by Region, 2020 - 2023, USD Million
TABLE 22 Global HRD Testing Market by Region, 2024 - 2031, USD Million
TABLE 23 Global HRR Testing Market by Region, 2020 - 2023, USD Million
TABLE 24 Global HRR Testing Market by Region, 2024 - 2031, USD Million
TABLE 25 Global Others Market by Region, 2020 - 2023, USD Million
TABLE 26 Global Others Market by Region, 2024 - 2031, USD Million
TABLE 27 Global PARP Inhibitor Biomarkers Market by Region, 2020 - 2023, USD Million
TABLE 28 Global PARP Inhibitor Biomarkers Market by Region, 2024 - 2031, USD Million
TABLE 29 North America PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 30 North America PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 31 North America PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 32 North America PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 33 North America Kits Market by Region, 2020 - 2023, USD Million
TABLE 34 North America Kits Market by Region, 2024 - 2031, USD Million
TABLE 35 North America Assays Market by Region, 2020 - 2023, USD Million
TABLE 36 North America Assays Market by Region, 2024 - 2031, USD Million
TABLE 37 North America PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 38 North America PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 39 North America Breast Cancer Market by Country, 2020 - 2023, USD Million
TABLE 40 North America Breast Cancer Market by Country, 2024 - 2031, USD Million
TABLE 41 North America Ovarian Cancer Market by Country, 2020 - 2023, USD Million
TABLE 42 North America Ovarian Cancer Market by Country, 2024 - 2031, USD Million
TABLE 43 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 44 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 45 North America PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 46 North America PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 47 North America BRCA 1 & 2 Testing Market by Country, 2020 - 2023, USD Million
TABLE 48 North America BRCA 1 & 2 Testing Market by Country, 2024 - 2031, USD Million
TABLE 49 North America HRD Testing Market by Country, 2020 - 2023, USD Million
TABLE 50 North America HRD Testing Market by Country, 2024 - 2031, USD Million
TABLE 51 North America HRR Testing Market by Country, 2020 - 2023, USD Million
TABLE 52 North America HRR Testing Market by Country, 2024 - 2031, USD Million
TABLE 53 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 54 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 55 North America PARP Inhibitor Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 56 North America PARP Inhibitor Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 57 US PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 58 US PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 59 US PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 60 US PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 61 US PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 62 US PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 63 US PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 64 US PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 65 Canada PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 66 Canada PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 67 Canada PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 68 Canada PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 69 Canada PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 70 Canada PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 71 Canada PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 72 Canada PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 73 Mexico PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 74 Mexico PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 75 Mexico PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 76 Mexico PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 77 Mexico PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 78 Mexico PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 79 Mexico PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 80 Mexico PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 81 Rest of North America PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 82 Rest of North America PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 83 Rest of North America PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 84 Rest of North America PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 85 Rest of North America PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 86 Rest of North America PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 87 Rest of North America PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 88 Rest of North America PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 89 Europe PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 90 Europe PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 91 Europe PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 92 Europe PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 93 Europe Kits Market by Country, 2020 - 2023, USD Million
TABLE 94 Europe Kits Market by Country, 2024 - 2031, USD Million
TABLE 95 Europe Assays Market by Country, 2020 - 2023, USD Million
TABLE 96 Europe Assays Market by Country, 2024 - 2031, USD Million
TABLE 97 Europe PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 98 Europe PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 99 Europe Breast Cancer Market by Country, 2020 - 2023, USD Million
TABLE 100 Europe Breast Cancer Market by Country, 2024 - 2031, USD Million
TABLE 101 Europe Ovarian Cancer Market by Country, 2020 - 2023, USD Million
TABLE 102 Europe Ovarian Cancer Market by Country, 2024 - 2031, USD Million
TABLE 103 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 104 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 105 Europe PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 106 Europe PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 107 Europe BRCA 1 & 2 Testing Market by Country, 2020 - 2023, USD Million
TABLE 108 Europe BRCA 1 & 2 Testing Market by Country, 2024 - 2031, USD Million
TABLE 109 Europe HRD Testing Market by Country, 2020 - 2023, USD Million
TABLE 110 Europe HRD Testing Market by Country, 2024 - 2031, USD Million
TABLE 111 Europe HRR Testing Market by Country, 2020 - 2023, USD Million
TABLE 112 Europe HRR Testing Market by Country, 2024 - 2031, USD Million
TABLE 113 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 114 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 115 Europe PARP Inhibitor Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 116 Europe PARP Inhibitor Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 117 Germany PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 118 Germany PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 119 Germany PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 120 Germany PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 121 Germany PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 122 Germany PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 123 Germany PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 124 Germany PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 125 UK PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 126 UK PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 127 UK PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 128 UK PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 129 UK PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 130 UK PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 131 UK PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 132 UK PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 133 France PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 134 France PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 135 France PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 136 France PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 137 France PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 138 France PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 139 France PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 140 France PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 141 Russia PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 142 Russia PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 143 Russia PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 144 Russia PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 145 Russia PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 146 Russia PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 147 Russia PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 148 Russia PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 149 Spain PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 150 Spain PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 151 Spain PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 152 Spain PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 153 Spain PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 154 Spain PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 155 Spain PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 156 Spain PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 157 Italy PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 158 Italy PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 159 Italy PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 160 Italy PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 161 Italy PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 162 Italy PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 163 Italy PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 164 Italy PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 165 Rest of Europe PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 166 Rest of Europe PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 167 Rest of Europe PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 168 Rest of Europe PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 169 Rest of Europe PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 170 Rest of Europe PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 171 Rest of Europe PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 172 Rest of Europe PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 173 Asia Pacific PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 174 Asia Pacific PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 175 Asia Pacific PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 176 Asia Pacific PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 177 Asia Pacific Kits Market by Country, 2020 - 2023, USD Million
TABLE 178 Asia Pacific Kits Market by Country, 2024 - 2031, USD Million
TABLE 179 Asia Pacific Assays Market by Country, 2020 - 2023, USD Million
TABLE 180 Asia Pacific Assays Market by Country, 2024 - 2031, USD Million
TABLE 181 Asia Pacific PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 182 Asia Pacific PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 183 Asia Pacific Breast Cancer Market by Country, 2020 - 2023, USD Million
TABLE 184 Asia Pacific Breast Cancer Market by Country, 2024 - 2031, USD Million
TABLE 185 Asia Pacific Ovarian Cancer Market by Country, 2020 - 2023, USD Million
TABLE 186 Asia Pacific Ovarian Cancer Market by Country, 2024 - 2031, USD Million
TABLE 187 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 188 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 189 Asia Pacific PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 190 Asia Pacific PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 191 Asia Pacific BRCA 1 & 2 Testing Market by Country, 2020 - 2023, USD Million
TABLE 192 Asia Pacific BRCA 1 & 2 Testing Market by Country, 2024 - 2031, USD Million
TABLE 193 Asia Pacific HRD Testing Market by Country, 2020 - 2023, USD Million
TABLE 194 Asia Pacific HRD Testing Market by Country, 2024 - 2031, USD Million
TABLE 195 Asia Pacific HRR Testing Market by Country, 2020 - 2023, USD Million
TABLE 196 Asia Pacific HRR Testing Market by Country, 2024 - 2031, USD Million
TABLE 197 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 198 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 199 Asia Pacific PARP Inhibitor Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 200 Asia Pacific PARP Inhibitor Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 201 China PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 202 China PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 203 China PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 204 China PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 205 China PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 206 China PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 207 China PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 208 China PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 209 Japan PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 210 Japan PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 211 Japan PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 212 Japan PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 213 Japan PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 214 Japan PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 215 Japan PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 216 Japan PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 217 India PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 218 India PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 219 India PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 220 India PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 221 India PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 222 India PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 223 India PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 224 India PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 225 South Korea PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 226 South Korea PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 227 South Korea PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 228 South Korea PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 229 South Korea PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 230 South Korea PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 231 South Korea PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 232 South Korea PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 233 Singapore PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 234 Singapore PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 235 Singapore PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 236 Singapore PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 237 Singapore PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 238 Singapore PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 239 Singapore PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 240 Singapore PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 241 Malaysia PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 242 Malaysia PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 243 Malaysia PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 244 Malaysia PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 245 Malaysia PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 246 Malaysia PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 247 Malaysia PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 248 Malaysia PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 249 Rest of Asia Pacific PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 250 Rest of Asia Pacific PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 251 Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 252 Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 253 Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 254 Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 255 Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 256 Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 257 LAMEA PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 258 LAMEA PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 259 LAMEA PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 260 LAMEA PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 261 LAMEA Kits Market by Country, 2020 - 2023, USD Million
TABLE 262 LAMEA Kits Market by Country, 2024 - 2031, USD Million
TABLE 263 LAMEA Assays Market by Country, 2020 - 2023, USD Million
TABLE 264 LAMEA Assays Market by Country, 2024 - 2031, USD Million
TABLE 265 LAMEA PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 266 LAMEA PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 267 LAMEA Breast Cancer Market by Country, 2020 - 2023, USD Million
TABLE 268 LAMEA Breast Cancer Market by Country, 2024 - 2031, USD Million
TABLE 269 LAMEA Ovarian Cancer Market by Country, 2020 - 2023, USD Million
TABLE 270 LAMEA Ovarian Cancer Market by Country, 2024 - 2031, USD Million
TABLE 271 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 272 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 273 LAMEA PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 274 LAMEA PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 275 LAMEA BRCA 1 & 2 Testing Market by Country, 2020 - 2023, USD Million
TABLE 276 LAMEA BRCA 1 & 2 Testing Market by Country, 2024 - 2031, USD Million
TABLE 277 LAMEA HRD Testing Market by Country, 2020 - 2023, USD Million
TABLE 278 LAMEA HRD Testing Market by Country, 2024 - 2031, USD Million
TABLE 279 LAMEA HRR Testing Market by Country, 2020 - 2023, USD Million
TABLE 280 LAMEA HRR Testing Market by Country, 2024 - 2031, USD Million
TABLE 281 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 282 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 283 LAMEA PARP Inhibitor Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 284 LAMEA PARP Inhibitor Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 285 Brazil PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 286 Brazil PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 287 Brazil PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 288 Brazil PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 289 Brazil PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 290 Brazil PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 291 Brazil PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 292 Brazil PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 293 Argentina PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 294 Argentina PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 295 Argentina PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 296 Argentina PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 297 Argentina PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 298 Argentina PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 299 Argentina PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 300 Argentina PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 301 UAE PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 302 UAE PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 303 UAE PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 304 UAE PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 305 UAE PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 306 UAE PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 307 UAE PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 308 UAE PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 309 Saudi Arabia PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 310 Saudi Arabia PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 311 Saudi Arabia PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 312 Saudi Arabia PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 313 Saudi Arabia PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 314 Saudi Arabia PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 315 Saudi Arabia PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 316 Saudi Arabia PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 317 South Africa PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 318 South Africa PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 319 South Africa PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 320 South Africa PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 321 South Africa PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 322 South Africa PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 323 South Africa PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 324 South Africa PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 325 Nigeria PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 326 Nigeria PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 327 Nigeria PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 328 Nigeria PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 329 Nigeria PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 330 Nigeria PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 331 Nigeria PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 332 Nigeria PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 333 Rest of LAMEA PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 334 Rest of LAMEA PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 335 Rest of LAMEA PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 336 Rest of LAMEA PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 337 Rest of LAMEA PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 338 Rest of LAMEA PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 339 Rest of LAMEA PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 340 Rest of LAMEA PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 341 Key Information – Myriad Genetics, Inc.
TABLE 342 Key Information – Thermo Fisher Scientific, Inc.
TABLE 343 key information – Illumina, Inc.
TABLE 344 Key Information – neogenomics, inc.
TABLE 345 Key Information – Qiagen N.V.
TABLE 346 key Information – Agilent Technologies, Inc.
TABLE 347 key Information – Merck KGaA
TABLE 348 Key Information – Bayer AG
TABLE 349 Key Information – AstraZeneca PLC
TABLE 350 Key Information – GlaxoSmithKline PLC

List of Figures
FIG 1 Methodology for the research
FIG 2 Global PARP Inhibitor Biomarkers Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting PARP Inhibitor Biomarkers Market
FIG 4 Porter’s Five Forces Analysis – PARP Inhibitor Biomarkers Market
FIG 5 Global PARP Inhibitor Biomarkers Market share by Product, 2023
FIG 6 Global PARP Inhibitor Biomarkers Market share by Product, 2031
FIG 7 Global PARP Inhibitor Biomarkers Market by Product, 2020 - 2031, USD Million
FIG 8 Global PARP Inhibitor Biomarkers Market share by Application, 2023
FIG 9 Global PARP Inhibitor Biomarkers Market share by Application, 2031
FIG 10 Global PARP Inhibitor Biomarkers Market by Application, 2020 - 2031, USD Million
FIG 11 Global PARP Inhibitor Biomarkers Market share by Services, 2023
FIG 12 Global PARP Inhibitor Biomarkers Market share by Services, 2031
FIG 13 Global PARP Inhibitor Biomarkers Market by Services, 2020 - 2031, USD Million
FIG 14 Global PARP Inhibitor Biomarkers Market share by Region, 2023
FIG 15 Global PARP Inhibitor Biomarkers Market share by Region, 2031
FIG 16 Global PARP Inhibitor Biomarkers Market by Region, 2020 - 2031, USD Million
FIG 17 SWOT Analysis: Thermo Fisher Scientific, Inc.
FIG 18 Swot Analysis: Illumina, Inc.
FIG 19 Swot Analysis: Qiagen N.V.
FIG 20 Swot Analysis: Agilent Technologies, Inc.
FIG 21 Swot Analysis: Merck KGaA
FIG 22 Swot Analysis: Bayer AG
FIG 23 SWOT Analysis: AstraZeneca PLC
FIG 24 SWOT Analysis: GlaxoSmithKline PLC